Division of Hematology
Jump to Main Content

Patient Services

Overview | BMT Program | Breast Cancer program
Cancer Biology and Therapy | Hemostasis & Thrombosis Program | Oncology/Clinical Pharmacology
Thoracic Oncology Program | Sickle Cell Center
 

Post-Doctoral Fellowship in Oncology/Clinical Pharmacology
Duke University Medical Center, Comprehensive Cancer Center

This Fellowship will prepare physicians for careers in pharmaceutical research and development, in academia, in clinical research, or in a governmental agency that deals with drugs or therapeutics. Duke is one of fourteen NCI designated phase I centers of excellence. Glaxo-Smith-Kline (GSK) is one of the world's leading pharmaceutical companies, with a robust program in new cancer drug development. This fellowship is meant to take advantage of the combined expertise of both Duke and GSK in the design and conduct of innovative clinical trials with novel anti-cancer agents. This program will emphasize phase I studies that will incorporate pharmacology, imaging, and other biomarker/pharmacodynamic assessements.
Objectives of the fellowships are to:
  • develop a complete clinical drug research proposal, from conception and design to approval, which embodies the clinical and scientific principles basic to clinical research and drug development.
  • participate in the conduct of clinical drug trials that would result in publications in peer-reviewed professional journals and/or in reports suitable for submission for action by a regulatory agency.
  • apply appropriate ethical, legal, and regulatory issues to research involving investigational and marketed drugs.
  • gain experience as a clinical researcher in the academic, clinical and pharmaceutical fields.
The Duke GSK Fellowship is for a 2-year period beginning on July 1st of their second year of training in Duke’s Hematology/Oncology Fellowship Program, with an expectation that the Fellow will spend time at each location, the Comprehensive Cancer Center at Duke University and GlaxoSmithKline located in Research Triangle Park, approximately 20 minutes from Duke.
For additional information or to apply, contact:
Herbert Hurwitz, M.D.
Clinical Director, Phase I Program
Duke Comprehensive Cancer Center
Box 3052, Room 25132 Morris Bldg
Duke University Medical Center
Durham, NC 27710
Printer Friendly PageSend this Story to a Friend
© 2009, Duke University Health System   DHTS Web Services DHTS Web Services